Publications

Balancing the risk of major bleeding against vascular disease risk in people without atherosclerotic disease.

Hammami I. et al, (2025), Heart (British Cardiac Society), 111, 716 - 721

Role of primary and secondary care data in atrial fibrillation ascertainment: impact on risk factor associations, patient management, and mortality in UK Biobank.

Camm CF. et al, (2025), Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 27

Proteomic profiling identifies novel independent relationships between inflammatory proteins and myocardial infarction.

Valdes-Marquez E. et al, (2023), European journal of preventive cardiology, 30, 583 - 591

Apolipoprotein Proteomics for Residual Lipid-Related Risk in Coronary Heart Disease.

Clarke R. et al, (2023), Circulation research, 132, 452 - 464

Determining the Relationship Between Blood Pressure, Kidney Function, and Chronic Kidney Disease: Insights From Genetic Epidemiology.

Staplin N. et al, (2022), Hypertension (Dallas, Tex. : 1979), 79, 2671 - 2681

Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries.

Mishra A. et al, (2022), Nature, 612

Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants.

Aragam KG. et al, (2022), Nature genetics, 54, 1803 - 1815

Stroke genetics informs drug discovery and risk prediction across ancestries.

Mishra A. et al, (2022), Nature, 611, 115 - 123

Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials.

Cholesterol Treatment Trialists' Collaboration ., (2022), Lancet (London, England), 400, 832 - 845

Oxidized phospholipids on apolipoprotein B-100 versus plasminogen and risk of coronary heart disease in the PROCARDIS study.

Clarke R. et al, (2022), Atherosclerosis, 354, 15 - 22

Multi-phenotype analyses of hemostatic traits with cardiovascular events reveal novel genetic associations.

Temprano-Sagrera G. et al, (2022), Journal of thrombosis and haemostasis : JTH, 20, 1331 - 1349

Independent effects of adiposity measures on risk of atrial fibrillation in men and women: a study of 0.5 million individuals.

Camm CF. et al, (2022), International journal of epidemiology, 51, 984 - 995

Are polygenic risk scores for systolic blood pressure and LDL-cholesterol associated with treatment effectiveness, and clinical outcomes among those on treatment?

Tapela NM. et al, (2022), European journal of preventive cardiology, 29, 925 - 937

Genetic associations of adult height with risk of cardioembolic and other subtypes of ischemic stroke: A mendelian randomization study in multiple ancestries.

Linden AB. et al, (2022), PLoS medicine, 19

Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease.

HPS3/TIMI55-REVEAL Collaborative Group . et al, (2022), European heart journal, 43, 1416 - 1424

Robust estimates of heritable coronary disease risk in individuals with type 2 diabetes.

Grace C. et al, (2022), Genetic epidemiology, 46, 51 - 62

Smoking and COVID-19 outcomes: an observational and Mendelian randomisation study using the UK Biobank cohort.

Clift AK. et al, (2022), Thorax, 77, 65 - 73

CHALLENGES IN EXTRAPOLATION WHEN THERE ARE MULTIPLE HEALTH OUTCOMES

Willliam C. et al, (2022), VALUE IN HEALTH, 25, S358 - S358

Multiplexed apolipoprotein profiling advances the assessment of residual lipid-related cardiovascular risk

Schmidt L. et al, (2022), CARDIOVASCULAR RESEARCH, 118

The impact of atrial fibrillation and stroke risk factors on left atrial blood flow characteristics.

Spartera M. et al, (2021), European heart journal. Cardiovascular Imaging, 23, 115 - 123

Cookies on this website

Search results (148)